Stefano Milani

Stefano Milani

Auto-generated profile, based on publicly available information

Stefano Milani

Cristina Stasi, Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2006 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Open access
PDF file
MCM. Capanni
M. Capanni
FCF. Calella
F. Calella
MBM. R. Biagini
M. R. Biagini
SGS. Genise
S. Genise
LRLaura Raimondi
Laura Raimondi
ACA. Casini
A. Casini
Summary: Background  Recent studies suggest a role of n‐3 long‐chain polyunsaturated fatty acids (n‐3 PUFA) as peroxisome proliferator‐activated receptor‐α ligands in improving non‐alcoholic fatty liver disease (NAFLD) in rodents. However, data in humans are still lacking.Aim  To evaluate the efficacy of prolonged PUFA supplementation in patients with NAFLD.Methods  Fifty‐six patients with NAFLD were enrolled. Among the overall eligible patients, 42 assumed n‐3 PUFA 1‐g capsule daily for 12 months, whereas 14 refused the treatment and were analysed as controls. All patients underwent haematochemical and ultrasound follow‐up.Results  Polyunsaturated fatty acid supplementation significantly decreased serum aspartate transaminase (P = 0.003), alanine transaminase (P = 0.002), γ‐glutamyl transpeptidase (P = 0.03), triglycerides (P = 0.02) and fasting glucose (P = 0.02) in comparison with controls. Circulating arachidonate and n‐6/n‐3 fatty acid ratio was reduced (P = 0.0002, and P = 0.0001 respectively) in treated patients. Moreover, ultrasonography demonstrated improvement of liver echotexture after PUFA (P = 0.0001), and increase of Doppler perfusion index (P = 0.001), whereas no significant changes occurred in controls.Conclusions  Supplementation with n‐3 PUFA improves biochemical, ultrasonographic and haemodynamic features of liver steatosis. Our study supports the efficacy of n‐3 PUFA as a new therapeutic approach in the treatment of NAFLD.

1 February 1996 in Gastroenterology
Verified
Journal Article
Closed access
MPM Pinzani
M Pinzani
SMS Milani
S Milani
RFR De Franco
R De Franco
CGC Grappone
C Grappone
ACA Caligiuri
A Caligiuri
PGP Gentilini
P Gentilini

29 November 2005 in Hepatology
Verified
Journal Article
Open access
PDF file
SASara Aleffi
Sara Aleffi
IPIlaria Petrai
Ilaria Petrai
CBCristiana Bertolani
Cristiana Bertolani
MPMaurizio Parola
Maurizio Parola
SCSebastiano Colombatto
Sebastiano Colombatto
FMFabio Marra
Fabio Marra
Leptin upregulates collagen expression in hepatic stellate cells (HSCs), but the possible modulation of other actions has not been elucidated. The aim of this study was to investigate the expression and function of leptin receptors (ObR) in human HSCs and the biological actions regulated by leptin. Exposure of HSCs to leptin resulted in upregulation of monocyte chemoattractant protein 1 (MCP‐1) expression. Leptin also increased gene expression of the proangiogenic cytokines vascular endothelial growth factor (VEGF) and angiopoietin‐1, and VEGF was also upregulated at the protein level. Activated HSCs express ObRb and possibly other ObR isoforms. Exposure to leptin increased the tyrosine kinase activity of ObR immunoprecipitates and resulted in activation of signal transducer and activator of transcription 3. Several signaling pathways were activated by leptin in HSCs, including extracellular‐signal–regulated kinase, Akt, and nuclear factor κB, the latter being relevant for chemokine expression. Leptin also increased the abundance of hypoxia‐inducible factor 1α, which regulates angiogenic gene expression, in an extracellular‐signal–regulated kinase– and phoshatidylinositol 3‐kinase–dependent fashion. In vivo, leptin administration induced higher MCP‐1 expression and more severe inflammation in mice after acute liver injury. Conversely, in leptin‐deficient mice, the increase in MCP‐1 messenger RNA and mononuclear infiltration was less marked than in wild‐type littermates. Finally, ObR expression colocalized with VEGF and α‐smooth muscle actin after induction of fibrosis in rats. In conclusion, ObR activation in HSCs leads to increased expression of proinflammatory and proangiogenic cytokines, indicating a complex role for leptin in the regulation of the liver wound‐healing response.(HEPATOLOGY 2005;42:1339–1348.)

1 August 1992 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MPM Pinzani
M Pinzani
PFPaola Failli
Paola Failli
CRC Ruocco
C Ruocco
ACA Casini
A Casini
SMS Milani
S Milani
PGP Gentilini
P Gentilini
Liver perisinusoidal fat-storing cells (FSC) show morphological and ultrastructural characteristics similar to pericytes regulating local blood flow in other organs. In the present study we have analyzed whether FSC respond to local vasoconstrictors such as thrombin, angiotensin-II, and endothelin-1 with an increase in intracellular free calcium concentration ([Ca2+]i) coupled with effective cell contraction. All agonists tested induced a rapid and dose-dependent increase in [Ca2+]i followed by a sustained phase lasting several minutes in confluent monolayers of Fura-2-loaded human FSC. Pharmacological studies performed using different Ca2+ channel blockers indicated that, at least for thrombin and angiotensin-II, the sustained phase is due to the opening of voltage-sensitive membrane Ca2+ channels. To analyze the temporal and spatial dynamics of Ca2+ release in response to these agonists, we performed experiments on individual Fura-2-loaded human FSC using a dual wavelength, radiometric video imaging system. The rise in [Ca2+]i was exclusively localized to the cytoplasm, particularly in the branching processes. Increases in [Ca2+]i more than four-fold were associated with a simultaneous and transient reduction of cell area indicating reversible cell contraction. Our results indicate that the Ca(2+)-dependent contraction of human FSC in vitro may reflect a potential role in regulating sinusoidal blood flow in vivo.

30 April 2008 in Gut
Verified
Journal Article
Open access
PDF file
UAU Arena
U Arena
FVF Vizzutti
F Vizzutti
JAJ G Abraldes
J G Abraldes
GCG Corti
G Corti
Cristina StasiCristina Stasi
Cristina Stasi
MPM Pinzani
M Pinzani
Background: Transient elastography (TE) has received increasing attention as a means to evaluate disease progression in patients with chronic liver disease. Aim: To assess the value of TE for predicting the stage of fibrosis. Methods: Liver biopsy and TE were performed in 150 consecutive patients with chronic hepatitis C-related hepatitis (92 men and 58 women, age 50.6 (SD 12.5) years on the same day. Necro-inflammatory activity and the degree of steatosis at biopsy were also evaluated. Results: The areas under the curve for the prediction of significant fibrosis (⩾F2), advanced fibrosis (⩾F3) or cirrhosis were 0.91, 0.99 and 0.98, respectively. Calculation of multilevel likelihood ratios showed that values of TE <6 or ⩾12, <9 or ⩾12, and <12 or ⩾18, clearly indicated the absence or presence of significant fibrosis, advanced fibrosis, and cirrhosis, respectively. Intermediate values could not be reliably associated with the absence or presence of the target condition. The presence of inflammation significantly affected TE measurements in patients who did not have cirrhosis (p<0.0001), even after adjusting for the stage of fibrosis. Importantly, TE measurements were not influenced by the degree of steatosis. Conclusions: TE is more suitable for the identification of patients with advanced fibrosis than of those with cirrhosis or significant fibrosis. In patients in whom likelihood ratios are not optimal and do not provide a reliable indication of the disease stage, liver biopsy should be considered when clinically indicated. Necro-inflammatory activity, but not steatosis, strongly and independently influences TE measurement in patients who do not have cirrhosis.

1 May 2012 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
CLCarmela Loguercio
Carmela Loguercio
PAPietro Andreone
Pietro Andreone
CBCiprian Brisc
Ciprian Brisc
MBMichaela Cristina Brisc
Michaela Cristina Brisc
EBElisabetta Bugianesi
Elisabetta Bugianesi
AFAlessandro Federico
Alessandro Federico